Nanomedicine Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Browse Full Research Report on <strong>Nanomedicine</strong> <strong>Market</strong>:<br />
http://www.transparencymarketresearch.com/nanomedicine-market.html<br />
On the basis of application, the report segments the global nanomedicine<br />
market into oncology, anti-inflammatory, neurology, cardiovascular,<br />
anti-infectives, and other applications. In 2012, the overall market was<br />
dominated by the oncology segment, which accounted for around 38.0%<br />
of the market. This can be attributed to the extensive usage of<br />
commercialized nanomedicine products in the field of oncology.<br />
However, during the next couple of years, the cardiovascular segment is<br />
expected to display the fastest growth owing to the growing geriatric<br />
population and increasing demand for nanomedicine-based devices and<br />
drugs for the treatment of cardiovascular diseases.<br />
The report studies the global nanomedicine market according to its<br />
performance in four key regional segments: Asia Pacific, North America,<br />
Europe, and Rest of the World. In 2012, North America dominated the<br />
overall market and is expected to continue its dominance during the<br />
forecast horizon.<br />
Advanced healthcare infrastructure has attributed to the growth of the<br />
market in this region. However, during the period between 2013 and<br />
2019, Asia Pacific is forecast to expand at a 14.6% CAGR and emerge<br />
as the fastest growing region in the market. Rising awareness about
Change language